Showing results (631-640 of 688) with videos related to

Sort By:
Pageof 69
The Lancet. Rheumatology|January 26, 2024
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL BalancePeter Nash, Philip J Mease, Dona Fleishaker, et al.
Diabetes Care|July 9, 2017
Skeletal Muscle Microvascular-Linked Improvements in Glycemic Control From Resistance Training in Individuals With Type 2 DiabetesRyan D Russell, Donghua Hu, Timothy Greenaway, et al.
Australian and New Zealand Journal of Public Health|February 13, 2024
Balancing the risks and benefits of sun exposure: A revised position statement for Australian adultsRachel E Neale, Victoria Beedle, Peter R Ebeling, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb TrialMark C Genovese, César Pacheco-Tena, Arturo Covarrubias, et al.
Arthritis Research & Therapy|May 16, 2023
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritisJuergen Braun, Ricardo Blanco, Helena Marzo-Ortega, et al.
Arthritis Research & Therapy|September 5, 2021
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENTJürgen Braun, Ricardo Blanco, Helena Marzo-Ortega, et al.
Diabetologia|July 12, 2018
Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trialJoseph Proietto, Jaret Malloy, Dongliang Zhuang, et al.
Aging Clinical and Experimental Research|February 16, 2021
Knee osteoarthritis and time-to all-cause mortality in six community-based cohorts: an international meta-analysis of individual participant-level dataKirsten M Leyland, Lucy S Gates, Maria T Sanchez-Santos, et al.
Human Molecular Genetics|February 3, 2009
Common variants in the region around Osterix are associated with bone mineral density and growth in childhoodNicholas J Timpson, Jon H Tobias, J Brent Richards, et al.
Modern Rheumatology|December 15, 2021
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1)Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Pageof 69